Niccolai, R., Göbel, C., Ndoj, K., Kreft, M., Kuiken, H. J., Lieftink, C., . . . Jacobs, H. (2025). Cholesterol biosynthesis as a drug-induced vulnerability in diffuse large B cell lymphoma insensitive to EZH2 inhibition. Neoplasia (New York, N.Y.), 70, 101243. https://doi.org/10.1016/j.neo.2025.101243
Chicago-Zitierstil (17. Ausg.)Niccolai, Rachele, et al. "Cholesterol Biosynthesis as a Drug-induced Vulnerability in Diffuse Large B Cell Lymphoma Insensitive to EZH2 Inhibition." Neoplasia (New York, N.Y.) 70 (2025): 101243. https://doi.org/10.1016/j.neo.2025.101243.
MLA-Zitierstil (9. Ausg.)Niccolai, Rachele, et al. "Cholesterol Biosynthesis as a Drug-induced Vulnerability in Diffuse Large B Cell Lymphoma Insensitive to EZH2 Inhibition." Neoplasia (New York, N.Y.), vol. 70, 2025, p. 101243, https://doi.org/10.1016/j.neo.2025.101243.